PanGenetics

Manufacturing, Pharmaceutical
Founded in 1995-01-01
Utrecht, Utrecht, The Netherlands
http://www.pangenetics.com
For Profit

About PanGenetics

PanGenetics B.V. develops monoclonal antibodies for the treatment of immune mediated diseases. PanGenetics is a clinical development company that specializes in taking antibodies from the late research stage through to clinical proof of concept. The company is based in Utrecht, the Netherlands with an office in Cambridge, UK. PanGenetics employs a lean business model with manufacturing and clinical development activities outsourced to specialist providers. Apart from PG110, the other clinical program of PanGenetics is PG102, a CD40 antagonist for treatment of autoimmune diseases which is currently being evaluated in a clinical study in psoriatic arthritis patients

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: 3 active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 52714851 USD
  • Last Funding: 23000000 EUR (Series C)
  • Funding Status: M&A

Technology Stack

PanGenetics actively uses 3 products in their tech stack.

Market Presence

Industries: Manufacturing, Pharmaceutical

Headquarters: Utrecht, Utrecht, The Netherlands